AstraZeneca's diabetes drug curbs heart failure, kidney risks

* Risk of hospitalisation due to heart failure cut by 27 pct

* No clear benefit in preventing heart attacks or strokes

* AstraZeneca hopes Farxiga data will expand drug's use